NexGel Total Long Term Liabilities 2021-2024 | NXGL

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

NexGel total long term liabilities from 2021 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

NexGel total long term liabilities from 2021 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.

Related Stocks
Company Name	Market Cap
Thermo Fisher Scientific (TMO)	$212.5B
Intuitive Surgical (ISRG)	$180.7B
Alcon (ALC)	$45.5B
Edwards Lifesciences (EW)	$40B
IQVIA Holdings (IQV)	$38.1B
IDEXX Laboratories (IDXX)	$33.9B
DexCom (DXCM)	$27.2B
Waters (WAT)	$23B
STERIS (STE)	$22.3B
SONOVA HOLDING (SONVY)	$22B
Hologic (HOLX)	$19.4B
Fresenius Medical Care AG KGaA (FMS)	$11.8B
Sysmex ADR (SSMXY)	$11.6B
Globus Medical (GMED)	$10.1B
Teleflex (TFX)	$9.6B
Penumbra (PEN)	$8.8B
Masimo (MASI)	$7.8B
Glaukos (GKOS)	$7.2B
PROCEPT BioRobotics (PRCT)	$5.1B
Integer Holdings (ITGR)	$4.2B
Inari Medical (NARI)	$2.9B
TransMedics (TMDX)	$2.9B
Veracyte (VCYT)	$2.7B
LivaNova (LIVN)	$2.7B
Nihon Kohden (NHNKY)	$2.6B
Elekta AB (EKTAY)	$2.3B
Tandem Diabetes Care (TNDM)	$2.2B
RxSight (RXST)	$1.9B
Integra LifeSciences Holdings (IART)	$1.9B
Alphatec Holdings (ATEC)	$1.2B